Related Experiment Videos
Enhanced hypoxic pulmonary vasoconstriction in hypertension.
M D Guazzi1, M Alimento, M Berti
1Istituto di Cardiologia, University of Milan, Italy.
Circulation
|February 1, 1989
Summary
Systemic hypertension enhances hypoxic pulmonary vasoconstriction, leading to increased pulmonary arteriolar resistance during low oxygen exposure. Calcium channel blockers effectively reduced this enhanced response.
Area of Science:
- Cardiovascular Physiology
- Pulmonary Medicine
- Hypertension Research
Background:
- Systemic hypertension is linked to elevated pulmonary vessel tone and reactivity.
- Alveolar hypoxia constricts pulmonary vessels by increasing smooth muscle cell calcium.
- Hypertension may alter smooth muscle cell calcium handling, potentially potentiating hypoxic responses.
Purpose of the Study:
- To test if hypoxic pulmonary vasoconstriction is enhanced in systemic hypertension.
- To investigate the role of calcium in this enhanced response.
Main Methods:
- Pulmonary arteriolar resistance was measured in hypertensive and normotensive men during varying oxygen levels.
- Responses were analyzed in relation to oxygen concentration, catecholamines, and hypocapnia.
- The effect of nifedipine (a calcium channel blocker) was assessed.
Main Results:
- Hypertensive individuals exhibited a steeper and left-shifted pulmonary arteriolar resistance curve during hypoxia, indicating enhanced vasoconstriction.
- This enhanced response was independent of stimulus severity, catecholamines, or hypocapnia.
- Nifedipine significantly attenuated pulmonary vasoconstriction in both groups.
Conclusions:
- Hypoxic pulmonary vasoconstriction is indeed enhanced in systemic hypertension.
- Calcium influx appears to be a critical mediator of this enhanced vasoconstriction.
- These findings suggest potential therapeutic targets for managing pulmonary vascular changes in hypertension.